JAHA:吸烟与致命和非致命心血管疾病亚型的竞争风险

2021-11-21 MedSci原创 MedSci原创

当前吸烟与作为临床CVD首要表现的致命事件相关。

尽管减少烟草使用的意识和公共卫生措施不断提高,但美国约有3400万成年人吸烟。烟草使用是导致残疾调整生命年的主要原因,也是导致死亡的第二大危险因素。与吸烟相关的疾病估计每年在美国直接医疗保健和生产力损失超过3000亿美元。吸烟与过早死亡显著相关,但与血管疾病(CVD)无关。与吸烟相关的风险在CVD亚型中是否相似尚不清楚。

近日,心血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员汇集并统一了来自美国9个基于人群的队列的个人水平数据。所有参与者在基线时都没有临床CVD,并有关于当前吸烟状况、协变量和CVD结局的可用数据。

研究人员评估了吸烟状况与总CVD和CVD亚型之间的关联,包括致死性和非致死性冠心病、卒中、充血性心力衰竭和其他CVD死亡。研究人员进行了(1)修正的Kaplan-Meier分析以估计长期风险,(2)调整竞争Cox模型以估计CVD或非心血管死亡的联合累积风险,以及(3)Irwin的限制平均数来估计不伴有和伴有心血管疾病的年份。

在106165名成年人中,50.4%是女性。中年男性和女性CVD事件的总体长期风险分别为46.0%(95%CI为44.7-47.3)和34.7%(95%CI为33.3-36.0)。在报告吸烟的中年男性中,与不吸烟的男性相比,首次出现致命CVD事件的竞争风险比(HR)更高(HR为1.79[95%CI为1.68-1.92]),女性之间的相似模式(HR为1.82[95%CI为1.68–1.98])。吸烟与男性和女性CVD发病提前5.1年和3.8年相关。在年轻人和老年人中观察到了类似的模式。

由此可见,当前吸烟与作为临床CVD首要表现的致命事件相关。

原始出处:

Sadiya S. Khan,et al.Cigarette Smoking and Competing Risks for Fatal and Nonfatal Cardiovascular Disease Subtypes Across the Life Course.JAHA.2021.https://www.ahajournals.org/doi/10.1161/JAHA.121.021751

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1268691, encodeId=019a126869176, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498970, encodeId=8e2b14989e06a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072677, encodeId=e30910e267755, content=好好学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Mon Nov 22 06:08:50 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072537, encodeId=cd8810e2537e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Sun Nov 21 16:34:03 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072500, encodeId=548810e250080, content=学习学习学习学习已读已读已读已读已读已读已读已读已读已读已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Nov 21 13:14:15 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-23 zhaohui6731
  2. [GetPortalCommentsPageByObjectIdResponse(id=1268691, encodeId=019a126869176, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498970, encodeId=8e2b14989e06a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072677, encodeId=e30910e267755, content=好好学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Mon Nov 22 06:08:50 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072537, encodeId=cd8810e2537e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Sun Nov 21 16:34:03 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072500, encodeId=548810e250080, content=学习学习学习学习已读已读已读已读已读已读已读已读已读已读已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Nov 21 13:14:15 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1268691, encodeId=019a126869176, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498970, encodeId=8e2b14989e06a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072677, encodeId=e30910e267755, content=好好学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Mon Nov 22 06:08:50 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072537, encodeId=cd8810e2537e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Sun Nov 21 16:34:03 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072500, encodeId=548810e250080, content=学习学习学习学习已读已读已读已读已读已读已读已读已读已读已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Nov 21 13:14:15 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-22 moyanju2796

    好好学习。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1268691, encodeId=019a126869176, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498970, encodeId=8e2b14989e06a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072677, encodeId=e30910e267755, content=好好学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Mon Nov 22 06:08:50 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072537, encodeId=cd8810e2537e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Sun Nov 21 16:34:03 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072500, encodeId=548810e250080, content=学习学习学习学习已读已读已读已读已读已读已读已读已读已读已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Nov 21 13:14:15 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-21 未来将来

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1268691, encodeId=019a126869176, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498970, encodeId=8e2b14989e06a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 23 03:17:47 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072677, encodeId=e30910e267755, content=好好学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Mon Nov 22 06:08:50 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072537, encodeId=cd8810e2537e4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Sun Nov 21 16:34:03 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072500, encodeId=548810e250080, content=学习学习学习学习已读已读已读已读已读已读已读已读已读已读已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Nov 21 13:14:15 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-21 ms5000000518166734

    学习学习学习学习已读已读已读已读已读已读已读已读已读已读已读

    0

相关资讯

Tobacco Control:中国必须遏制吸烟,未来二十年,与吸烟相关癌死亡将增加50%

2021年11月1日,中国医学科学院肿瘤医院徐宁志和北京协和医学院姜晶梅等研究人员在 BMJ 子刊" Tobacco Control "期刊发表了一篇题为" Smoking-related cance

Clin Infectious Dis:儿童远离吸烟患者可以降低患结核的风险

烟草消费,尤其是吸烟,正威胁着全球结核病的控制工作。最近的研究表明,在结核病高负担国家,18%的结核病病例和15%的结核病死亡率可归因于吸烟。

大部分女性不抽烟,为何还会得肺癌?

最近数据显示,2000~2014年间,我国女性的肺癌发病率从27.77/10万增长到51.31/10万,翻了将近一倍,她们中约80%从不吸烟,从不吸烟女性患肺癌的可能性是从未吸烟男性的两倍。

Thorax:吸烟影响新冠肺炎预后?

吸烟与新冠肺炎风险及严重程度的相关性?

Thorax:吸烟对特发性肺纤维化发展的影响

吸烟显著增加了IPF的风险。相比于既往吸烟者,当前吸烟者患IPF的风险更高,并在吸烟和IPF之间观察到了剂量-反应关系。

从不吸烟与既往吸烟的肺癌患者空气污染暴露情况比较

从不吸烟的肺癌患者与女性、亚裔和空气污染暴露密切相关。